With the Medicare Access and CHIP Reauthorization Act (MACRA) set to take effect January 1, 2017, The American Journal of Managed Care has created a resource center, the MACRA Compendium, where payers and providers can find updates on the transition to value-based care.
FOR IMMEDIATE RELEASEDecember 22, 2016
PLAINSBORO, N.J.—If you still don’t understand the Medicare Access and CHIP Reauthorization Act (MACRA), you’re not alone. While small practices have the greatest learning curve, even larger health systems may benefit from a convenient source of information on the 2015 law, which takes effect January 1, 2017.
With that in mind, The American Journal of Managed Care (AJMC) has created the MACRA Compendium, a resource center on www.ajmc.com that brings together news, commentary, and multimedia content on the law, which pushes Medicare’s transition from fee-for-service to value-based payment. You can find the center at http://www.ajmc.com/compendium/macra.
The MACRA Compendium features content from:
· The fall meeting of AJMC’s ACO & Emerging Healthcare Delivery Coalition, which discussed how accountable care organizations have laid the groundwork for MACRA.
· Commentary from several AJMC contributors, including Greg Fulton of Philips Wellcentive and heath information technology strategist Mark Heaney.
· Video interviews with CMS’ Kate Goodrich, MD, on how physicians can successfully adapt to the Merit-Based Incentive Payment System.
To contribute commentary to the MACRA Compendium, contact Editorial Director Nicole Beagin at (609) 716-7777 x 131.
About the Journals and AJMC.com
The American Journal of Managed Care is the leading peer-reviewed journal dedicated to issues in managed care. AJMC.com distributes healthcare news to leading stakeholders across a variety of platforms. Other titles in the franchise include The American Journal of Accountable Care, which publishes research and commentary on innovative healthcare delivery models facilitated by the 2010 Affordable Care Act. AJMC’s Evidence-Based series brings together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
,
Semaglutide Eligibility Expands to Over Half of US Adults
November 21st 2024Over half of the US adult population may benefit from semaglutide, a drug primarily used for weight loss and diabetes, although concerns about access and cost persist, especially considering its potential for wider health applications.
Read More
New Study Finds Risk Groups, Outpatient Care Barriers in Chronic Liver Disease
November 20th 2024Patients with chronic liver disease who were unable to establish care were 85% more likely to require recurrent hospitalizations. This group included a disproportionate number of women and individuals with physical limitations affecting their health.
Read More